Home › Boehringer Ingelheim Selects Genedata Biologics as Antibody Discovery Workflow Platform
 

Keywords :   


Boehringer Ingelheim Selects Genedata Biologics as Antibody Discovery Workflow Platform

2015-02-23 11:30:53| Industrial Newsroom - All News for Today

Genedata Biologics integrates and streamlines workflows for protein therapeutics RD groups across multiple Boehringer Ingelheim sites Basel, Switzerland  Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Boehringer Ingelheim has chosen...

Tags: platform discovery antibody workflow

Category:Industrial Goods and Services

Latest from this category

All news
31.10Consolidated Financial Statements for the six-month period ended September 30, 2024
31.10Notice regarding the revision of the business results forecasts
Industrial Goods and Services »
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »